Vitreous Wick Syndrome

Vitreous Wick Syndrome is a problem that happens when strands of the eye’s vitreous (the clear, gel-like substance that fills the back of the eye) slip forward and get stuck in a surgical opening or wound in the front part of the eye. Think of the vitreous strand as a “wick”—like a piece of thread that runs from inside the eye to the surface. Because it touches both the inside and the outside, it can pull germs into the eye, drag and tug on delicate eye tissues, block fluid flow, and keep the wound from sealing properly. This can cause ongoing inflammation, abnormal eye pressure (too high or too low), blurry vision, corneal irregularity, macular swelling, and even serious infections such as endophthalmitis.

Vitreous Wick Syndrome happens when a tiny strand of the eye’s gel (the vitreous) pokes forward and gets stuck inside, or even through, a surgical or traumatic wound at the front of the eye. That strand behaves like a “wick” or thread. It can tug on inside tissues, keep the wound from sealing perfectly, keep inflammation going, change eye pressure, blur vision, and in rare cases provide a path for germs to enter (increasing infection risk). It is most often seen after cataract surgery when the back capsule has broken or zonules are weak, but it can also appear after trauma, glaucoma filtering surgery (bleb), or intravitreal injections. The core problem is vitreous prolapse with incarceration in a wound, which must be identified and removed or lysed to restore a quiet, sealed, stable eye. EyeWiki+1PubMed+1

In healthy eyes, the vitreous stays behind the lens and its capsule and never reaches the cornea or the surgical incision. In Vitreous Wick Syndrome, a break in the normal barriers—often after eye surgery, trauma, or a wound that did not close perfectly—allows vitreous to move forward. Once a vitreous strand is trapped in the wound, it behaves like a rope under tension: it keeps pulling, keeps irritating, and keeps the entry pathway open. This is why the condition can persist until the strand is properly dealt with.

Pathophysiology

1. Barrier failure: A tear or defect (for example, a posterior capsule rupture during cataract surgery, a sclerotomy during vitrectomy, or a leaky corneal or scleral wound) lets vitreous move forward.

2. Vitreous prolapse: The gel pushes into the opening and may become incarcerated (trapped).

3. Wick effect: The trapped vitreous strand acts like a wick. It can wick tears or bacteria, prevent the wound edges from sealing, and transmit traction to the retina or ciliary body.

4. Complications: The wick can lead to persistent inflammation, corneal irregular astigmatism, raised eye pressure (if it blocks the drainage angle), low pressure (if the wound leaks), cystoid macular edema (CME) from traction/inflammation, retinal tears or detachment from ongoing pull, and endophthalmitis if germs travel along the strand.

---

Types

1. Anterior wound vitreous wick
   Vitreous protrudes into a corneal or limbal incision (often after cataract surgery or corneal surgery). The strand sits right in the wound and keeps it irritated and open. This type is strongly linked to surface contamination and the risk of infection traveling inward.

2. Scleral tunnel vitreous wick
   The vitreous strand is caught in a scleral tunnel (the hidden passage made during certain surgeries). Because the tunnel is long, it can hold vitreous like a straw holds a string, allowing chronic leakage, inflammation, or hypotony (low pressure).

3. Trabeculectomy site vitreous wick
   After glaucoma filtering surgery (trabeculectomy), vitreous can plug the sclerostomy. This can cause blockage of aqueous outflow, high pressure, bleb failure, or, the opposite, over-filtration and low pressure if the wound leaks around it.

4. Pars plana sclerotomy vitreous incarceration (posterior wick)
   During or after pars plana vitrectomy, vitreous can get trapped in the sclerotomy (the small opening on the white of the eye). This can produce traction, retinal tears, hypotony, or recurrent inflammation, especially if the sclerotomy does not seal fully.

5. Contact-lens-associated wound wick (rare)
   If a wound is slightly open and a contact lens is used, micro-movement and tear film flow can encourage vitreous to remain at the wound edge, acting like a wick and preventing full closure. This is uncommon but illustrates how surface mechanics can sustain a wick.

6. Trauma-related vitreous wick
   After penetrating eye injury, the vitreous can prolapse through the entry site and become a wick. Because trauma introduces outside material, the infection risk is particularly high.

7. Graft-host junction wick (post-keratoplasty)
   After corneal transplant, gaps at the graft–host junction can trap vitreous. The result can be chronic inflammation, astigmatism, and delayed wound healing.

8. Incision-edge epithelialized wick
   If the incision edges become epithelialized (covered by surface cells) while a vitreous strand is in place, a false channel may form. The wick then persists longer and becomes harder to resolve, with ongoing irritation.

---

Causes

1. Posterior capsule rupture during cataract surgery – Break in the lens capsule lets vitreous move forward.

2. Inadequate anterior vitrectomy – Not removing prolapsed vitreous fully leaves strands at the wound.

3. Leaky corneal or limbal incision – A gap keeps pulling vitreous into the wound with each blink.

4. Poorly sealed scleral tunnel – The tunnel behaves like a pipeline for vitreous strands.

5. Pars plana sclerotomy not closing fully – After vitrectomy, a soft eye or large cannula can leave an opening.

6. Glaucoma filtering surgery (trabeculectomy) sclerostomy – The drainage opening can snag vitreous.

7. Penetrating ocular trauma – Injury creates a direct path for vitreous prolapse.

8. Post-keratoplasty wound gap – Small gaps at the corneal graft edge can trap vitreous.

9. High vitreous pressure during/after surgery – Pressure pushes vitreous forward through any weak spot.

10. Zonular weakness or dialysis – Weak support of the lens complex lets vitreous migrate forward.

11. Large incision size – Bigger wounds are harder to seal and more likely to catch vitreous.

12. Inadequate suturing of the wound – Loose or absent sutures allow micro-leaks and vitreous incarceration.

13. Excess eye rubbing or squeezing post-op – Increases pressure and promotes vitreous prolapse.

14. Early, forceful eyelid squeezing (blepharospasm) – Similar mechanism: spikes pressure, pulls vitreous forward.

15. Hypotony (very low eye pressure) – A soft eye can “suck” vitreous toward the opening like a vacuum.

16. Infection or inflammation at the wound – Swelling prevents proper sealing, encouraging incarceration.

17. Use of contact lenses on a marginally sealed wound – Micro-movement can keep the channel open.

18. Inadequate management of posterior pressure during surgery – Not controlling pressure lets vitreous push forward.

19. Repeat entrance through the same wound – Re-using an incision can disturb sealing and snag vitreous.

20. Delayed healing due to systemic factors – Diabetes, poor nutrition, or steroid overuse can slow wound closure and favor a wick.

---

Symptoms

1. Blurry vision – Vision goes in and out of focus because the wound is irritated and the cornea can become irregular.

2. Foreign-body sensation – Feels like something is in the eye because the wound edges are rubbed by the strand.

3. Eye pain or ache – From ongoing inflammation or pressure changes.

4. Red eye – Persistent redness due to surface irritation and internal inflammation.

5. Light sensitivity (photophobia) – Inflammation makes light uncomfortable.

6. Tearing or watery eye – Reflex tearing from irritation or wound leak.

7. Fluctuating vision during the day – As pressure or corneal shape changes, vision may fluctuate.

8. Halos or glare at night – Irregular cornea and tear film cause scatter of light.

9. Headache around the eye – From strain or elevated pressure.

10. Eye pressure symptoms (too high) – Rainbow halos, brow ache, nausea (if pressure spikes).

11. Eye pressure symptoms (too low) – Dull ache, shadowy or wavy vision from macular folds in hypotony.

12. Floaters – Vitreous traction can cause floaters or light flashes.

13. Decreased contrast sensitivity – Vision seems “washed out” due to optical irregularity or macular edema.

14. Slow visual recovery after surgery – Vision doesn’t improve as expected because inflammation persists.

15. Worsening pain/redness with discharge (warning sign) – Could indicate infection (endophthalmitis) and needs urgent care.

---

Diagnostic tests

A) Physical Exam

1. History and symptom review
   The doctor asks about surgery, trauma, timing of symptoms, pain, vision changes, and pressure issues. Because wick problems follow an incision or wound, the timeline is a vital clue.

2. Visual acuity testing (Snellen chart)
   Measures clarity of vision. Fluctuating or reduced acuity suggests corneal irregularity, inflammation, or macular edema.

3. External inspection
   The doctor looks at the eyelids and eye surface for redness, discharge, tearing, and wound tenderness, which point toward irritation or leak.

4. Slit-lamp biomicroscopy (anterior segment exam)
   A microscope exam of the cornea, incision, anterior chamber, iris, lens, and any visible vitreous strand. The examiner may see shiny, stringy material (vitreous) caught in the wound, plus cells/flare from inflammation.

5. Dilated fundus examination
   With the pupil enlarged by safe drops, the doctor examines the vitreous cavity, retina, and optic nerve for traction, tears, detachment, or macular edema.

B) Manual Tests

6. Intraocular pressure measurement (applanation tonometry)
   Checks eye pressure. High pressure suggests blockage of fluid outflow (e.g., vitreous blocking the angle). Low pressure suggests a leak.

7. Seidel test (with fluorescein dye)
   A drop of dye is placed on the eye surface while viewing under blue light. If the wound leaks, clear aqueous fluid will dilute the dye and create a bright green stream, proving a wound leak that can feed a wick.

8. Gonioscopy (angle exam with a lens)
   A special contact lens shows the drainage angle. The doctor looks for vitreous strands in the angle, peripheral anterior synechiae, or blockage that explains pressure problems.

9. Scleral depression (carefully performed)
   Gentle pressure on the outer white of the eye lets the doctor see the far peripheral retina to look for retinal tears caused by vitreous traction.

10. Wound stability assessment (gentle manipulation at the slit lamp)
    Very careful probing with instruments (or observing wound edges during blinking) can show wound gape, tissue incarceration, or movement of a vitreous strand, supporting the diagnosis.

C) Lab and Pathological Tests

11. Aqueous tap for Gram stain and culture
    If infection is suspected, a tiny sample of the front-chamber fluid is tested for bacteria/fungi. A wick can let germs in, so this test can be sight-saving.

12. Vitreous tap/biopsy for culture and PCR
    In more severe cases or when endophthalmitis is suspected, sampling the vitreous gel itself improves the chance of identifying the germ using culture or PCR (a DNA test).

13. Conjunctival swab culture (adjacent to wound)
    Swabbing the area near the wound can identify surface organisms that might be wicking inward.

14. Complete blood count (CBC) and inflammatory markers (ESR/CRP)
    Not specific to the eye, but helpful if there is a systemic infection or high inflammation burden.

15. Fungal workup (KOH prep, fungal culture, or PCR)
    Considered if the wound course is indolent, if the patient has risk factors (immunosuppression), or if surgery occurred in a warm/humid environment—fungal endophthalmitis needs different treatment.

D) Electrodiagnostic Tests

16. Full-field electroretinography (ERG)
    Measures the electrical function of the retina. If chronic traction or inflammation has harmed retinal cells, the ERG may be reduced.

17. Pattern ERG or multifocal ERG (mERG)
    Gives more detailed information about the macula. Helpful when cystoid macular edema is suspected and vision is out of proportion to the front-of-eye findings.

18. Visual evoked potential (VEP)
    Measures signals from the eye to the brain. Used when optic nerve function is in question and the front-of-eye status does not fully explain poor vision.

E) Imaging Tests

19. Anterior segment OCT (AS-OCT)
    A non-contact scan that shows cross-sections of the cornea, incision, and angle. It can reveal a vitreous strand in the wound, gaps, or tiny fluid pockets.

20. Ultrasound biomicroscopy (UBM)
    High-frequency ultrasound that images the front structures in detail, especially useful when the cornea is cloudy. It can visualize vitreous at the angle or wound.

21. B-scan ocular ultrasound
    Useful if the view to the back is cloudy. It can show posterior vitreous traction, retinal tears, or detachment related to the wick.

22. Macular OCT
    A non-contact scan of the macula to detect cystoid macular edema or macular folds from hypotony, both potential consequences of a vitreous wick.

23. Wide-field fundus photography
    Documents retinal status, hemorrhages, and peripheral lesions that may result from traction.

24. Fluorescein angiography (FA)
    Highlights leaky retinal blood vessels and helps confirm CME or retinal ischemia when vision is reduced.

25. Scheimpflug or corneal topography/tomography
    Maps corneal shape. Shows irregular astigmatism from wound distortion caused by the incarcerated vitreous strand.

Non-pharmacological treatments (therapies & others)

1. Close observation with activity modification — Short-term rest, avoid rubbing/bending/heavy lifting to reduce vitreous traction while arranging definitive treatment. Purpose: prevent worsening. Mechanism: lowers mechanical stress on the strand. (General surgical care principle.)

2. Protective eye shield at night — Keeps you from rubbing the eye in sleep. Purpose: protect wound. Mechanism: physical barrier.

3. Strict eyelid hygiene if a filtering bleb is present — Warm compress and gentle lid care reduce surface bioburden. Purpose: lower infection risk in eyes with a bleb and a potential wick. Mechanism: decreases bacteria near a potential entry track. Nature

4. Temporary activity/positioning guidance — Avoid face-down or pressure on the eye; head-up posture reduces congestion. Purpose: minimize wound seepage. Mechanism: hydrostatic relief.

5. Artificial tears/lubrication — Comforts and supports the surface when inflammation makes the eye gritty. Purpose: symptom relief. Mechanism: dilutes inflammatory mediators on the surface.

6. UV-blocking glasses outdoors — Decreases photophobia and irritation. Purpose: comfort. Mechanism: reduce light-triggered ciliary spasm.

7. Chilled preservative-free lubricants — Cooling effect reduces surface hyperemia/irritation. Purpose: comfort. Mechanism: local vasoconstriction.

8. Warm compress (short, gentle) — Helps Meibomian flow if blepharitis coexists. Purpose: stabilize tear film. Mechanism: improves lipid layer, reducing reflex inflammation.

9. Avoid contact lens wear until cleared — Lenses can rub the wound or trap organisms. Purpose: reduce friction/infection risk. Mechanism: eliminates a foreign body interface.

10. Hygienic intravitreal-injection technique (for future care) — If you need injections later, meticulous antisepsis reduces new wicks at injection sites. Purpose: prevent repeat wicks/infection. Mechanism: minimizes track formation. Retina Today

11. Suture support or wound protection (clinician-directed) — External reinforcement while planning definitive vitrectomy. Purpose: seal. Mechanism: mechanical closure. American Academy of Ophthalmology

12. Laser vitreolysis counseling — Education about in-office Nd:YAG cut of the strand, including benefits/limits. Purpose: informed consent. Mechanism: photodisruption of the vitreous thread. American Academy of Ophthalmology+1

13. Return-precautions education — Teach warning signs: pain, pus-like discharge, sudden blur, new floaters, curtain, fever. Purpose: early detection of complications. Mechanism: rapid care lowers risk of vision loss. (General safety standard.)

14. Glycemic control and BP control — Systemic control reduces edema and helps healing; diabetes raises infection risk. Purpose: faster recovery. Mechanism: better microvascular stability.

15. Smoking cessation — Smoking delays wound healing. Purpose: better outcomes. Mechanism: improved oxygenation & immune response.

16. Treat blepharitis/meibomian disease — Reduces surface bacteria and inflammation. Purpose: lower infection risk. Mechanism: reduced lid margin biofilm near wound. (General peri-op ophthalmology standard.)

17. Avoid miotic drops unless specifically directed — Miotics can pull vitreous forward in compromised eyes. Purpose: avoid worsening prolapse. Mechanism: ciliary body/pupil effects that may favor anterior movement. (Clinical caution with vitreous prolapse.)

18. Cold compress for acute photophobia — Short-term relief. Purpose: comfort. Mechanism: vasoconstriction.

19. Nutritional optimization (see diet section) — Adequate protein, omega-3s, vitamins A/C/E, zinc. Purpose: tissue repair. Mechanism: supports collagen and antioxidant balance. (General ocular nutrition principles.)

20. Tear-film and surface optimization before any re-intervention — Pre-op surface optimization improves visualization and reduces risk. Purpose: safer laser/surgery. Mechanism: better optics and lower load of pathogens.

---

Drug treatments

Doses below are typical adult examples and must be individualized by your ophthalmologist.

1. Prednisolone acetate 1% (topical corticosteroid) • 1 drop q.i.d., then taper over 2–4 weeks • Purpose: calm intraocular inflammation from vitreous tug. Mechanism: blocks inflammatory cascade (COX/LOX gene expression). Side effects: steroid IOP rise, delayed wound healing, rare infection masking. (Standard in anterior segment inflammation)

2. Atropine 1% (cycloplegic/mydriatic) • 1 drop b.i.d.–q.i.d. for several days to a week • Purpose: pain relief and break ciliary spasm; stabilize iris. Mechanism: muscarinic blockade; rest to ciliary muscle. Side effects: light sensitivity, near blur, rare angle closure in predisposed eyes. (Common in traumatic/irritative uveitis care)

3. Ketorolac 0.5% or Nepafenac 0.1/0.3% (topical NSAIDs) • q.i.d. (ketorolac) or b.i.d.–t.i.d. (nepafenac) • Purpose: reduce CME risk and pain. Mechanism: COX inhibition reduces prostaglandins. Side effects: sting, rare corneal issues with prolonged use. (Used to manage/postvent CME) ekjo.org

4. Timolol 0.5% (topical beta-blocker) • b.i.d. • Purpose: lower IOP if elevated. Mechanism: reduces aqueous production. Side effects: bronchospasm/bradycardia (systemic absorption), burning. (Standard glaucoma agent)

5. Brimonidine 0.2% (alpha-2 agonist) • t.i.d. • Purpose: additional IOP lowering. Mechanism: decreases aqueous production, increases uveoscleral outflow. Side effects: allergy, dry mouth, fatigue.

6. Dorzolamide 2% (topical CAI) • t.i.d. • Purpose: IOP control. Mechanism: blocks carbonic anhydrase in ciliary body. Side effects: stinging, bitter taste; caution in sulfa allergy.

7. Mannitol IV (hyperosmotic, clinic/hospital use) • 0.5–1 g/kg IV once for urgent, very high IOP not responding to drops • Purpose: emergency pressure lowering before surgery. Mechanism: osmotic dehydration of vitreous. Side effects: fluid/electrolyte shifts; avoid in CHF/renal failure. (General ophthalmic emergency practice)

8. Topical fluoroquinolone (e.g., moxifloxacin 0.5%) • q.i.d. short course when a wick is exposed at the surface or after laser/suture manipulation • Purpose: reduce surface bacteria while the wound reseals. Mechanism: DNA gyrase inhibition. Side effects: mild sting; stewardship to avoid resistance. (Prophylaxis principle around exposed tracts) PMC

9. Oral NSAID (e.g., ibuprofen 200–400 mg q6–8h with food; max per label) • Purpose: pain and prostaglandin control. Mechanism: COX inhibition systemically. Side effects: GI upset, renal risks; avoid if contraindicated.

10. Periocular or intraocular steroid (specialist-administered; e.g., sub-Tenon’s triamcinolone) • Dose per surgeon • Purpose: stubborn inflammation/CME. Mechanism: intense local anti-inflammatory effect. Side effects: IOP rise, cataract progression in phakic eyes. (Adjunct in refractory inflammation/CME)

---

Dietary “molecular” supplements

Always share supplements with your doctor; they are adjuncts, not cures for VWS.

1. Omega-3 (DHA/EPA 1,000–2,000 mg/day) • Anti-inflammatory milieu; membrane fluidity • Eicosanoid balancing.

2. Vitamin A (up to 2,500–3,000 IU/day unless pregnant) • Epithelial health • Supports mucin/epithelium.

3. Vitamin C (500–1,000 mg/day) • Collagen cross-linking & antioxidant • Scavenges free radicals.

4. Vitamin E (≤200 IU/day unless advised) • Antioxidant synergy with C • Lipid membrane protection.

5. Zinc (10–25 mg/day) • Co-factor in repair • DNA/RNA polymerase support.

6. Lutein + Zeaxanthin (10 mg + 2 mg/day) • Macular antioxidant support • Filters blue light, quenches ROS.

7. Curcumin (up to 500–1,000 mg/day standardized) • Systemic anti-inflammatory • NF-κB modulation.

8. Resveratrol (100–250 mg/day) • Antioxidant/vascular support • Sirtuin/oxidative stress pathways.

9. CoQ10 (100–200 mg/day) • Mitochondrial support • Electron transport chain cofactor.

10. Collagen peptides (5–10 g/day) • Structural protein supply • Provides amino acids for repair.

(Evidence for these relates to general ocular/surgical healing and retinal antioxidant support; they do not replace definitive vitreolysis/vitrectomy.)

---

Regenerative / stem-cell” drugs

There are no approved “immunity-booster,” stem-cell, or regenerative drugs for treating Vitreous Wick Syndrome. Definitive care is mechanical (laser/surgical removal of the strand). Below are items sometimes discussed around ocular healing; where agents are off-label or investigational, I note this clearly—not recommendations:

1. Autologous serum tears 20% (off-label; 1 drop q.i.d.–q6/day to surface issues) — Supports ocular surface healing if surface disease coexists; not a VWS cure. Mechanism: growth factors/vitamins from your serum.

2. Platelet-rich plasma (PRP) eye drops (investigational; dosing protocols vary) — Rich in growth factors for surface repair; not an internal vitreous treatment.

3. Cenegermin (recombinant human nerve growth factor) 0.002% (approved for neurotrophic keratitis; 1 drop 6×/day for 8 weeks) — For corneal nerve healing only; not indicated for VWS.

4. Amniotic membrane (cryopreserved/sutureless devices) — A biologic scaffold for surface regeneration; used for epithelial issues, not for vitreous wicks.

5. Intravitreal cell therapies (various stem cells) — Do not use. Multiple warnings exist about severe complications (retinal detachment, blindness) with unregulated intravitreal “stem cell” injections; not recommended outside trials.

6. Intravitreal anti-VEGF or methotrexate for PVR — These are problem-specific agents in other retinal conditions; not treatments for VWS. Use only if your retina specialist indicates a separate indication.

Bottom line: in VWS, the “regeneration” is removing the traction source and letting normal tissues calm down; unapproved biologics are not substitutes.

---

Surgeries / procedures

1. Nd:YAG laser vitreolysis (in-clinic laser “cut”) — A focused laser pulse cuts the thin vitreous strand at the pupil edge or wound. Why: First-line in many cases; quick, no incisions. Effect: instantly removes mechanical wick if well-visualized. American Academy of Ophthalmology+1

2. Anterior vitrectomy via limbal approach — Tiny instruments remove vitreous from the anterior chamber/wound; the wound is sutured securely. Why: When laser can’t safely reach or the strand is broad/combined with capsule issues. Effect: eliminates traction and reseals the entrance. American Academy of OphthalmologyScienceDirect

3. Pars plana vitrectomy (PPV; limited or 25–27G transconjunctival) — A retina surgeon removes anterior and any tractional posterior vitreous under microscope visualization. Why: Persistent traction, CME, or posterior involvement. Effect: definitive clearance and stabilization. PMC

4. Incision/wound revision with resuturing — The original corneal/scleral wound is refreshed and tightly sutured after vitreous removal. Why: To stop micro-leaks and prevent the vitreous from creeping forward again. Effect: restores a sealed barrier. American Academy of Ophthalmology

5. Filtering bleb/Trabeculectomy revision (when wick involves a bleb) — The surgeon removes vitreous from the sclerostomy and revises the bleb. Why: To reduce infection risk and stabilize IOP in glaucoma eyes with vitreous at the bleb. Effect: lowers risk of bleb-related endophthalmitis. PMCEurope PMC

---

Preventions

1. Meticulous cataract/trauma surgery technique (capsular support, gentle nucleus handling).

2. Immediate anterior vitrectomy whenever vitreous prolapses (don’t leave strands). EyeWiki

3. Secure wound closure with sutures when needed (don’t accept micro-leaks). American Academy of Ophthalmology

4. Avoid pulling vitreous with sponges (“no-no”)—vitrectomize instead. CRSTodayCRST Global

5. Use triamcinolone staining to find occult vitreous before ending the case. American Academy of Ophthalmology

6. Careful technique with intravitreal injections to avoid vitreous tracks. Retina Today

7. Protect and monitor filtering blebs (thin blebs have infection risk; seek early care if redness/pain). Nature

8. Post-op shields and “no rubbing” rules.

9. Prompt treatment of ocular inflammation (CME/uveitis) after surgery. ekjo.org

10. Systemic health optimization (diabetes, smoking).

---

When to see a doctor urgently

• Sudden, new or worsening blurred vision, pulsing pain, or light sensitivity.

• New floaters or flashes, or a “curtain” (possible retinal tear/detachment).

• Red eye with discharge, swelling, or fever (possible infection).

• Eye pressure symptoms: severe headache, eye ache, halos, nausea.

• After any laser/suture, if vision worsens instead of improving.

• If you have a filtering bleb and notice redness, tenderness, or discharge—same day. PMC

---

What to eat” and “what to avoid

Eat more:

1. Protein-rich foods (fish, eggs, legumes) for tissue repair.

2. Fatty fish (salmon, sardines) for omega-3s.

3. Leafy greens (spinach/kale) for lutein/zeaxanthin.

4. Colorful fruits/veg (berries, citrus) for vitamins C/A.

5. Nuts/seeds (almonds, walnuts, flax) for vitamin E and ALA.

Limit/avoid:

1. Smoking and secondhand smoke (delays healing).
2. Excess alcohol (dehydrates, raises inflammation).
3. Very salty/ultra-processed foods (fluid shifts; not helpful for pressure or healing).
4. Sugary drinks (worsen glycemic control).
5. Unregulated supplements or “stem-cell” eye products sold online.

---

Frequently Asked Questions (FAQs)

1) Can Vitreous Wick Syndrome go away on its own?
Sometimes minor strands quiet down with drops and time, but a true wick usually needs laser or surgical removal to stop traction and fully seal the wound. American Academy of Ophthalmology+1

2) Is Nd:YAG laser safe and effective?
In properly selected cases, anterior-segment vitreolysis can quickly cut the strand and improve symptoms; published series reported good improvement with low complications. Your surgeon will assess visibility and safety. PubMedScienceDirect

3) What if laser isn’t possible?
Then an anterior vitrectomy or pars plana vitrectomy is performed to remove the vitreous and close the wound securely. American Academy of OphthalmologyScienceDirect

4) Will I need stitches?
If the wound shows any leak or instability, yes—suturing helps prevent the wick from returning. American Academy of Ophthalmology

5) Can a vitreous wick cause infection?
Yes—especially in eyes with a filtering bleb, a wick can be a conduit for bacteria, increasing risk of bleb-related endophthalmitis. Rapid evaluation is essential if redness/pain/vision loss occur. PMCEurope PMC

6) Is it the same as vitreous prolapse?
Vitreous prolapse means vitreous has moved forward; a wick is a prolapsed strand incarcerated in a wound, acting like a thread that keeps problems going. EyeWiki

7) Why does my pupil look peaked or pulled?
The strand can pull on the iris, creating a notch or peaked pupil until it’s cut/removed. American Academy of Ophthalmology

8) Can it cause macular swelling (CME)?
Yes—traction and inflammation can lead to CME; anti-inflammatory drops and definitive removal of the wick are used. ekjo.org

9) Will eye pressure be high or low?
Either can happen—blockage or inflammation can raise IOP; wound leak or ciliary shutdown can lower it. Drops address pressure while the wick is treated. (General pathophysiology; see surgical/AAO references.)

10) Is rubbing my eye dangerous now?
Yes. Rubbing can worsen traction or leak—use a shield as instructed.

11) Can this happen after an injection?
Yes—rarely, a vitreous strand can form at an injection site, especially with certain needles; technique matters. Retina Today

12) Will it affect my cornea?
Chronic incarceration can cause corneal edema or decompensation; another reason to remove the wick. PubMed

13) What’s the long-term outlook?
With proper laser/surgery and drop therapy, most eyes stabilize and see well, especially if treated early and if the macula is healthy. (Consensus clinical experience; see AAO/EyeWiki.) EyeWiki

14) Can I fly or exercise?
After the surgeon confirms stability, routine travel and light exercise are fine. Avoid heavy lifting until cleared.

15) Are “stem-cell” injections an option?
No. Intravitreal “stem-cell” injections are not approved for VWS and have caused severe harms in unregulated settings. Stick with proven laser/surgery. (Professional safety consensus.)

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 30, 2025.